Related Experiment Video
Updated: Dec 13, 2025

09:44
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
10.5K
Dramatic radiotherapy response in a necrotic lymphoma mass: a case report
Nicholas McNeil1, Peter Gorayski2,3, Danielle Blunt2
1Royal Adelaide Hospital, Adelaide, SA, Australia. nicholas.mcneil@sa.gov.au.
Journal of Medical Case Reports
|July 29, 2020
Summary
Palliative radiotherapy can dramatically reduce disease burden in elderly patients with early-stage diffuse large B-cell lymphoma (DLBCL). This approach offers durable local control and improved quality of life due to DLBCL
Area of Science:
- Oncology
- Radiation Oncology
- Hematology
Background:
- Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma, known for its aggressive progression.
- Lymphomas generally exhibit radiosensitivity, allowing for effective disease control with radiation therapy.
- Current guidelines lack consensus on radiotherapy use for DLBCL, particularly in elderly patients unfit for systemic therapy.
Observation:
- A 97-year-old female presented with a rapidly progressing, necrotic neck mass.
- Diagnostic investigations confirmed stage 1A DLBCL.
- The patient received palliative radiotherapy at a dose of 25 Gray in five fractions.
Findings:
- The patient experienced a complete resolution of the neck mass within four months post-treatment.
- No residual symptoms were reported, indicating significant disease burden reduction.
- The palliative radiotherapy resulted in durable local control.
Implications:
- Palliative radiotherapy can achieve dramatic and durable local control in elderly patients with early-stage DLBCL.
- This treatment modality significantly improves quality of life by reducing disease burden.
- The case highlights the potential of radiotherapy as a palliative option for patients ineligible for systemic therapy.